Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Older opioid with short action; largely replaced because of toxic metabolite. | The benchmark strong painkiller. |
| Body system | Pain & Fever | Pain & Fever |
| Drug class | Opioids | Opioids |
| Supply | Controlled drug | Controlled drugWHO essential medicine |
| Main uses | Severe pain, Labour pain (some regions), Shivering after anaesthesia (low dose) | Severe acute pain, Cancer pain, Pain after surgery, Heart attack pain, Breathlessness in palliative care |
| How it works | Strong painkiller that wears off quickly. | Switches on the body's own pain-control system in the brain and spinal cord. |
| Starts working | 10–15 minutes (IM) | 30–60 minutes by mouth; 5–10 minutes IV |
| Half-life | 3–5 hours (norpethidine 15–30 hours) | 2–3 hours |
| Typical adult dose | 50–100 mg IM or SC every 3–4 hours; oral up to 150 mg. | Opioid-naive adults: typically 5–10 mg by mouth every 4 hours as needed, adjusted to effect by a prescriber. |
| Forms | Injection, Tablet | Oral solution, Immediate-release tablet, Modified-release tablet or capsule, Injection, Suppository |
| Common side effects | Nausea, Drowsiness, Dizziness, Dry mouth, Constipation | Constipation, Nausea, Drowsiness, Itching, Dry mouth, Confusion in older people |
| Serious side effects | Seizures from norpethidine, Serotonin syndrome, Slow breathing, Dependence | Slowed or stopped breathing, Dependence and addiction, Low blood pressure, Severe drowsiness |
| Don't take if | Taking MAOIs (or within 2 weeks); Severe kidney impairment; Epilepsy; Head injury | Severe breathing problems or acute asthma; Head injury or raised pressure in the skull; Paralytic ileus; Taking an MAOI |
| Alcohol | Best avoided. Alcohol adds to dangerous drowsiness and breathing depression. | Best avoided. Alcohol adds to dangerous drowsiness and breathing depression. |
| Pregnancy | Use with cautionMay depress newborn breathing; use is limited. | Use with cautionUsed when needed; regular use near birth can cause withdrawal and breathing problems in the newborn. |
| Breastfeeding | Usually avoidedNorpethidine accumulates in the baby. | Use with cautionShort-term use is acceptable; watch the baby for drowsiness. |
| In use since | — | 1827 |
| Brand names | United States: DemerolUnited Kingdom: Pethidine (generic)India: Pethidine (generic), Demerol | United States: MS ContinUnited Kingdom: Oramorph, Zomorph, MST ContinusAustralia: MS Contin, Kapanol |
| Legal status | United States: Controlled substance (Schedule II)United Kingdom: Controlled drug (Schedule 2)India: Narcotic drug (NDPS Act) | United States: Controlled substance (Schedule II)United Kingdom: Controlled drug (Schedule 2)India: Narcotic drug (NDPS Act) |
| ATC code | N02AB02 | N02AA01 |
Taken together
- MajorPethidine + Morphine: Dangerous drowsiness and slowed breathing
Opioids combined with other opioids, benzodiazepines, gabapentinoids, sleeping tablets or sedating medicines can stop breathing. Many fatal overdoses involve such combinations.